LBRX LB Pharmaceuticals Inc
$44.63▼ -3.50%
Healthcare
Other
After hours
$44.26▼ -0.83%
Sep 11, 6:00 PM ET
Volume 208.4K
Avg Volume (10D) 274.8K
Key Metrics & Fundamentals
Market Cap
$1.44B
P/E Ratio
–
Div Yield
–%
52W Range
13.36 - 50.16
% vs 50 MA
7.04%
% vs 200 MA
52.24%
RSI-14
46.0
MACD Histogram
-0.7600
Beta (1Y vs SPY)
0.54
Free Cash Flow
-$37.99M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$53.16M
COGS
–
Operating Exp
$53.92M
Operating Income
-$53.92M
EBIT
-$53.92M
Pretax Income
-$51.60M
Net Income
-$51.60M
EPS (Diluted)
-1.71
Price & Volume History
Loading chart…
Recent News
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
Investor's Business Daily · Sep 9, 2026 12:00 PM
2 Reasons LB Pharmaceuticals (LBRX) Looks Pricey Following Its CFO Appointment
Simply Wall St. · Sep 4, 2026 10:15 AM
LB Pharmaceuticals to Participate in Upcoming September Investor Events
GlobeNewswire · Sep 3, 2026 8:05 PM
LB Pharmaceuticals Names Joseph Miller CFO
MT Newswires · Sep 3, 2026 12:38 PM
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
GlobeNewswire · Sep 3, 2026 12:00 PM
LB Pharmaceuticals Q2 Loss Per Share Narrows
MT Newswires · Aug 11, 2026 12:40 PM
LB Pharmaceuticals Inc.: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 12:07 PM
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 11, 2026 12:00 PM
LB Pharmaceuticals Announces $150 Million Private Placement
GlobeNewswire · Jul 29, 2026 12:00 PM
LB Pharmaceuticals Expects Phase-3 Schizophrenia Study's Topline Data in H1 2027
MT Newswires · Jul 22, 2026 12:54 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LBRX's money flow as a full page
Social Sentiment
No Reddit posts found for LBRX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.